InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OMEROS CORP

OMER Clue Score25
United States Fiscal year ends December CIK 0001285819 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Gregory A MD Demopulos
18 Feb 2026
Chairman, CEO & President
Exercised, kept
400,000
$10.27
$4.11M
Arnold C Hanish
8 Sep 2021
Director
Exercised, kept indirect
10,000
$9.44
$94.40K
Peter A MD Demopulos
22 Feb 2021
Director
Exercised, kept
5,000
$4.53
$22.65K
Peter A MD Demopulos
22 Feb 2021
Director
Exercised, kept
5,000
$5.30
$26.50K
Leroy E. MD PhD Hood
12 Feb 2021
Director
Exercised, kept
5,000
$4.53
$22.65K
Michael A Jacobsen
20 Jan 2021
VP Finance and CAO
Exercised, kept
10,000
$9.37
$93.70K
Leroy E. MD PhD Hood
13 Mar 2020
Director
Exercised, kept
5,000
$5.92
$29.60K
Peter A MD Demopulos
14 Dec 2019
Director
Exercised, kept
3,334
$7.56
$25.21K
Leroy E. MD PhD Hood
14 Dec 2019
Director
Exercised, kept
10,000
$7.56
$75.60K
Marcia S. Kelbon
7 Jun 2019
VP Patent and General Counsel
Exercised, kept
10,000
$6.05
$60.50K
Michael A Jacobsen
4 Jan 2018
VP Finance and CAO
Exercised, kept
1,000
$9.37
$9.37K
Gregory A MD Demopulos
28 Dec 2017
Chairman, CEO & President
Exercised, kept
39,961
$4.10
$163.84K
Gregory A MD Demopulos
28 Dec 2017
Chairman, CEO & President
Exercised, kept
102,040
$2.45
$250.00K
Marcia S. Kelbon
21 Aug 2017
VP Patent and General Counsel
Exercised, kept
8,000
$6.05
$48.40K
Marcia S. Kelbon
20 Mar 2017
VP Patent and General Counsel
Exercised, kept
2,040
$6.05
$12.34K
Show all 70 transactions →

What was left out

Form 4 filings counted 161
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 48
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,710,778
Sales filed before the plan box existed 4
History held since 13 Oct 2009